One particularly ugly symptom may be making a comeback.
TOKYO, June 1 (Reuters) - Japan's Shionogi & Co said on Monday the U.S. Food and Drug Administration has approved its oral ...
The FDA has approved the first and only pill to prevent COVID-19 after exposure to the virus. Here's how it works. (Photo: ...
The U.S. Supreme Court on Monday declined to hear a case challenging Washington state's COVID-19 vaccine mandate for ...
The drug showed promising results in an international study involving nearly 2,400 participants, and the U.S. Food and Drug ...
24don MSN
Pfizer didn't say hantavirus is side effect of its COVID-19 vaccine, contrary to online claims
Those eager to discredit Pfizer's mRNA vaccine, which is safe and effective, exploited the cruise ship outbreak.
The FDA recently approved ensitrelvir (Xocova; Shionogi), an anti–SARS-CoV-2 oral drug for post-exposure prophylaxis (PEP) of COVID-19, for adults and adolescents 12 years of age and older. 1 The ...
A former senior adviser at the National Institute of Allergy and Infectious Diseases is facing charges over an alleged scheme to hide federal records during the COVID-19 pandemic, the Justice ...
Although hantavirus can be deadly, researchers say the virus behaves very differently from COVID-19 and is easier to contain ...
Latest on cases, vaccines, masks and breakthrough infections This page updates monthly. Last update: Friday, Jan. 6, 12:33 p.m. Wondering about the state of Minnesota’s COVID-19 outbreak?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results